For example, higher expression of IGF2BP2 is associated with a poorer prognosis in HCC patients, and mechanistically, IGF2BP2 directly recognizes and binds to the m6A site of flap endonuclease-1 (FEN1), and maintains its mRNA expression 92. The gene discussed is FEN1; the disease is hepatocellular carcinoma.